tility of non-invasive fibrosis assessment for patients with chronic hepatitis C treated with telaprevir-based triple therapy
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000012850
- Lead Sponsor
- Department of General Internal Medicine, Kyushu University Hospital
- Brief Summary
An alternative to METAVIR score by liver biopsy, non-invasive fibrosis assessments are useful options for predicting SVR by prior partial or null responders in TVR-based triple therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1) positivity for antibody to human immunodeficiency virus or positivity for hepatitis B surface antigen; (2) clinical or biochemical evidence of hepatic decompensation (Child-Pugh B or C, ascites, bleeding varices, or encephalopathy); (3) other causes of liver disease; (4) excessive active alcohol consumption, drug abuse or severe mental disorder; (5) the presence of active cancer at entry; or (6) treatment with antiviral or immunosuppressive agents prior to enrollment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method